Wogonin Mitigates Depression by Inhibiting TNF‐α/TNFR1/CXCL1 Signalling‐Mediated Astrocyte Activation
Journal of Cellular and Molecular Medicine · 2026-03 · 30 (6)
DOI: 10.1111/jcmm.71116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 25.03.2026. Verfasst von Huihui Chai und 3 weiteren Autor:innen. Beteiligte Einrichtung: The National Key Clinic Specialty, the Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on …. Hauptthemen laut MEDLINE: Flavanones, Astrocytes, Tumor Necrosis Factor-alpha, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Medical Science and Technology Research Fund, Scientific Research and Development Fund of Dongguan People's Hospital.
Themen: Depression
Abstract (Originalsprache)
Wogonin exhibits notable anti‐inflammatory and neuroprotective effects. Current study aimed to investigate the antidepressant potential of wogonin and its underlying mechanisms through in vitro and in vivo experiments. In vitro, wogonin attenuated lipopolysaccharide (LPS)‐induced astrocyte activation. Furthermore, wogonin inhibited the TNF‐α/TNFR1/CXCL1 signalling axis, as evidenced by decreased protein levels of TNF‐α and CXCL1 and reduced interaction between TNF‐α and its receptor TNFR1. The addition of recombinant TNF‐α (r‐TNF‐α) blocked these inhibitory effects of wogonin. In vivo, in a chronic unpredictable mild stress (CUMS) mouse model, wogonin alleviated depression‐like behaviours. Moreover, wogonin rescued CUMS‐induced impairments in hippocampal synaptic plasticity, restoring post‐tetanic potentiation (PTP), long‐term potentiation (LTP) and mitigating neuronal damage in the CA1 region. Further analysis revealed that wogonin reduced levels of TNF‐α and CXCL1 in both the hippocampal CA1 region and cerebrospinal fluid, and decreased the expression of astrocyte activation markers GFAP and C3. These effects of wogonin in vivo were reversed by co‐administration of r‐TNF‐α and were replicated by treatment with the TNF‐α inhibitor etanercept. These results demonstrate that wogonin may exert antidepressant effects by modulating the TNF‐α/TNFR1/CXCL1 pathway, thereby improving neuroinflammation and astrocyte activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National Key Clinic Specialty, the Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Neurosurgery, Zh…
- School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, China.
- College of Modern Biomedical Industry, Kunming Medical University, Kunming, China.
- Department of Neurosurgery, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, China.
Förderung
- Guangdong Provincial Medical Science and Technology Research Fund
- Scientific Research and Development Fund of Dongguan People's Hospital
Zitieren
APA
Chai, H., Zhao, K., Hu, W., & Liu, B. (2026). Wogonin Mitigates Depression by Inhibiting TNF‐α/TNFR1/CXCL1 Signalling‐Mediated Astrocyte Activation. Journal of Cellular and Molecular Medicine, 30(6). https://doi.org/10.1111/jcmm.71116
Vancouver
Chai H, Zhao K, Hu W, Liu B. Wogonin Mitigates Depression by Inhibiting TNF‐α/TNFR1/CXCL1 Signalling‐Mediated Astrocyte Activation. Journal of Cellular and Molecular Medicine. 2026;30(6). doi:10.1111/jcmm.71116
BibTeX
@article{Chai2026,
author = {Chai, Huihui and Zhao, Kunying and Hu, Weiyan and Liu, Bin},
title = {Wogonin Mitigates Depression by Inhibiting TNF‐α/TNFR1/CXCL1 Signalling‐Mediated Astrocyte Activation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {6},
doi = {10.1111/jcmm.71116}
}
EUVIMED